NKTR

Nektar Therapeutics (NKTR) Earnings

Review Nektar Therapeutics (NKTR) earnings with company data, supporting context and links to related investor research.

Research record updated: . Individual measures may refer to different reporting periods.

Annual EPS
-9.73
Trailing EPS
-6.70
Annual revenue
$55.23M
Trailing revenue
$54.59M
Next earnings date
2026-08-13

Nektar Therapeutics (NKTR) Earnings research

The NKTR earnings page organizes the available earnings-per-share and revenue context for Nektar Therapeutics. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.

Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.